At Milo, we work hand-in-hand with healthcare professionals across Europe to simplify and improve how clinical research is conducted in real-world settings. In our latest video interview, we sat down with Dr. Axel Schulz, an orthopedic and trauma surgeon based in Germany, to hear about his experience using the Milo platform to streamline documentation and enhance patient engagement during clinical trials.
Meet Dr. Axel Schulz
Dr. Schulz is a seasoned clinician and investigator who brings a dual perspective — balancing daily patient care in a private orthopedic practice with active involvement in clinical research.
He has led both interventional and observational studies in musculoskeletal health, working with hospitals and primary care networks to bring real-world evidence to the forefront.
The challenges of real-world trials
“It all seems easy — until you face the bureaucracy.”
Dr. Schulz shared the common hurdles clinicians face when participating in research: managing complex inclusion/exclusion criteria, handling regulatory paperwork, and keeping documentation structured and accurate — all without disrupting patient care.
In outpatient settings, where time and resources are often stretched thin, these burdens can make research participation incredibly difficult.
How Milo changed the game
“With Milo, I didn’t dictate — I just spoke to my patient. Milo listened.”
What impressed Dr. Schulz most was Milo’s ability to listen passively during consultations and extract structured clinical data in real time. Without interrupting the natural flow of conversation, Milo captured his notes, observations — even ultrasound findings — and generated comprehensive reports that could be easily integrated into his EHR system.
“It’s pretty impressive. I even tried speaking while examining a patient, and Milo got everything right.”
Real efficiency for clinical research
One of the biggest takeaways from the interview is the time savings. Dr. Schulz estimates that Milo reduced his documentation workload by up to 66% — a game changer for busy private practices.
The platform also supported patient screening by automatically checking eligibility against protocol criteria — often a bottleneck that slows down or blocks recruitment.
“This is what ease of doing clinical research really looks like.”
